(Public, NASDAQ:BIOL)   Watch this stock  
Find more results for biol
+0.078 (9.96%)
Feb 10 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.75 - 0.86
52 week 0.60 - 2.63
Open 0.80
Vol / Avg. 94,958.00/120,970.00
Mkt cap 47.19M
P/E     -
Div/yield     -
EPS -0.38
Shares 58.23M
Beta 1.72
Inst. own 44%
Apr 26, 2016
BIOLASE Inc Annual Shareholders Meeting (Estimated) - 2:00PM EDT - Add to calendar
Mar 2, 2016
Q4 2015 BIOLASE Inc Earnings Release (Estimated) Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -47.56% -39.71%
Operating margin -47.64% -37.65%
EBITD margin - -36.19%
Return on average assets -43.52% -41.85%
Return on average equity -74.67% -74.90%
Employees 210 -
CDP Score - -


IRVINE, CA 92618-1816
United States - Map
+1-949-3611200 (Phone)
+1-949-2736677 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. The Company's dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. Combining its laser system products with imaging solutions provides dental professionals capabilities for early diagnosis and minimally invasive treatment. It markets and sells its laser systems in the United States, Canada, the European Union and other countries outside the United States.

Officers and directors

Paul N. Clark Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Harold C. Flynn Jr. President, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
David C. Dreyer CPA Chief Financial Officer
Age: 58
Bio & Compensation  - Reuters
Brendan O'Connell Vice President - Finance and Corporate Controller
Age: 38
Bio & Compensation  - Reuters
George W. Bickerstaff III Director
Age: 60
Bio & Compensation  - Reuters
Tamar D. Howson Director
Age: 67
Bio & Compensation  - Reuters
Terence A. Kelly Ph.D. Director
Age: 53
Bio & Compensation  - Reuters
Jonathan T. Lord M.D. Director
Age: 60
Bio & Compensation  - Reuters
Frederic H. Moll M.D. Director
Age: 61
Bio & Compensation  - Reuters